Brief: Pharvaris Reports FDA Acceptance of IND Application for Prophylactic Treatment of HAE Using PHVS416
21/04/2021 13:18
April 21 (Reuters) - Pharvaris BV PHVS.O :
* PHARVARIS ANNOUNCES FDA ACCEPTANCE OF IND APPLICATION FOR
PROPHYLACTIC TREATMENT OF HAE USING PHVS416
Source text for Eikon: ID:nGNX8461mN
Further company coverage: PHVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharvaris NV
See all newsSwitzerland's Pharvaris Q1 loss per share narrows
Brief: Pharvaris Announces Pricing Of $115 Million Underwritten Offering Of Ordinary Shares
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox
U.S. STOCKS ON THE MOVE-Microsoft, Wyndham Hotels & Resorts, Daktronics
U.S. STOCKS ON THE MOVE-Wendy's, Bristol Myers Squibb, Macy's